Quinolone: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Howard C. Berkowitz
No edit summary
imported>Howard C. Berkowitz
No edit summary
Line 1: Line 1:
{{subpages}}
{{subpages}}
In [[medicine]], '''quinolones''' are [[antibiotic]]s that are "a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid."<ref>{{MeSH}}</ref> [[Nadixilic acid]]'s effects are localized to the urinary tract, but it was the first quinolone in general use. The subsequent quinolones, with broader spectra, were fluorinated and are often called fluoroquinolones.
In [[medicine]], '''quinolones''' are [[antibiotic]]s that are "a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid."<ref>{{MeSH}}</ref> [[Nadixilic acid]]'s effects are localized to the urinary tract, but it was the first quinolone in general use. The subsequent quinolones, with broader spectra, were fluorinated and are often called fluoroquinolones.<ref name=GG>{{citation
| title = Goodman & Gilman's The Pharmacological Basis of Therapeutics
| edition = Ninth
| editor = Hardman JG, Limberd LE, Molinoff PB, Ruddon RW, Alfred Goodman Gilman
| publisher = McGraw-Hill | year = 1996}}, pp. 1065-1068}}</ref>


==Mode of action==
Quinolones inhibit the enzyme [[DNA gyrase]].
==Classes==
'Respiratory quinolones' are [[levofloxacin]], [[gatifloxacin]], or [[moxifloxacin]]. However, gatifloxacin can cause dysglycemia.<ref name="pmid16510739">{{cite journal| author=Park-Wyllie LY, Juurlink DN, Kopp A, Shah BR, Stukel TA, Stumpo C et al.| title=Outpatient gatifloxacin therapy and dysglycemia in older adults. | journal=N Engl J Med | year= 2006 | volume= 354 | issue= 13 | pages= 1352-61 | pmid=16510739  
'Respiratory quinolones' are [[levofloxacin]], [[gatifloxacin]], or [[moxifloxacin]]. However, gatifloxacin can cause dysglycemia.<ref name="pmid16510739">{{cite journal| author=Park-Wyllie LY, Juurlink DN, Kopp A, Shah BR, Stukel TA, Stumpo C et al.| title=Outpatient gatifloxacin therapy and dysglycemia in older adults. | journal=N Engl J Med | year= 2006 | volume= 354 | issue= 13 | pages= 1352-61 | pmid=16510739  
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=16510739 | doi=10.1056/NEJMoa055191 }} <!--Formatted by http://sumsearch.uthscsa.edu/cite/--></ref>
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=16510739 | doi=10.1056/NEJMoa055191 }} <!--Formatted by http://sumsearch.uthscsa.edu/cite/--></ref>


'Antipseudomonal quinolones' are [[ciprofloxacin]], [[levofloxacin]]
'Antipseudomonal quinolones' are [[ciprofloxacin]], [[levofloxacin]]
==References==
==References==
<references/>
<references/>

Revision as of 18:41, 6 September 2009

This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

In medicine, quinolones are antibiotics that are "a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid."[1] Nadixilic acid's effects are localized to the urinary tract, but it was the first quinolone in general use. The subsequent quinolones, with broader spectra, were fluorinated and are often called fluoroquinolones.[2]

Mode of action

Quinolones inhibit the enzyme DNA gyrase.

Classes

'Respiratory quinolones' are levofloxacin, gatifloxacin, or moxifloxacin. However, gatifloxacin can cause dysglycemia.[3]

'Antipseudomonal quinolones' are ciprofloxacin, levofloxacin

References

  1. Anonymous (2024), Quinolone (English). Medical Subject Headings. U.S. National Library of Medicine.
  2. Hardman JG, Limberd LE, Molinoff PB, Ruddon RW, Alfred Goodman Gilman, ed. (1996), Goodman & Gilman's The Pharmacological Basis of Therapeutics (Ninth ed.), McGraw-Hill, pp. 1065-1068}}
  3. Park-Wyllie LY, Juurlink DN, Kopp A, Shah BR, Stukel TA, Stumpo C et al. (2006). "Outpatient gatifloxacin therapy and dysglycemia in older adults.". N Engl J Med 354 (13): 1352-61. DOI:10.1056/NEJMoa055191. PMID 16510739. Research Blogging.